AMETEK, Inc. (NYSE:AME) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of AMETEK, Inc. (NYSE:AMEGet Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eleven analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $203.44.

Several research firms have recently weighed in on AME. BNP Paribas raised shares of AMETEK from a “neutral” rating to an “outperform” rating and set a $210.00 price target on the stock in a report on Thursday, January 16th. Bank of America raised AMETEK from a “neutral” rating to a “buy” rating and raised their price target for the company from $195.00 to $225.00 in a report on Monday, December 16th. Mizuho upped their price objective on shares of AMETEK from $190.00 to $200.00 and gave the stock an “outperform” rating in a research report on Friday, November 1st. Truist Financial lifted their target price on shares of AMETEK from $221.00 to $222.00 and gave the company a “buy” rating in a research report on Thursday, January 16th. Finally, Robert W. Baird increased their price target on shares of AMETEK from $166.00 to $186.00 and gave the stock a “neutral” rating in a report on Monday, November 4th.

Read Our Latest Stock Analysis on AMETEK

Insider Activity

In related news, insider Emanuela Speranza sold 6,747 shares of AMETEK stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $195.90, for a total value of $1,321,737.30. Following the transaction, the insider now directly owns 30,460 shares of the company’s stock, valued at $5,967,114. The trade was a 18.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Tony J. Ciampitti sold 16,210 shares of the firm’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $197.01, for a total transaction of $3,193,532.10. Following the completion of the sale, the insider now directly owns 49,490 shares in the company, valued at approximately $9,750,024.90. This trade represents a 24.67 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,200 shares of company stock valued at $5,707,620. Insiders own 0.61% of the company’s stock.

Institutional Investors Weigh In On AMETEK

Several institutional investors and hedge funds have recently bought and sold shares of AME. MassMutual Private Wealth & Trust FSB raised its holdings in shares of AMETEK by 4.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,450 shares of the technology company’s stock valued at $261,000 after acquiring an additional 63 shares in the last quarter. Hutchens & Kramer Investment Management Group LLC raised its holdings in AMETEK by 3.8% in the 3rd quarter. Hutchens & Kramer Investment Management Group LLC now owns 1,764 shares of the technology company’s stock worth $298,000 after purchasing an additional 65 shares in the last quarter. Miracle Mile Advisors LLC raised its holdings in AMETEK by 0.9% in the 3rd quarter. Miracle Mile Advisors LLC now owns 7,178 shares of the technology company’s stock worth $1,233,000 after purchasing an additional 66 shares in the last quarter. AlphaMark Advisors LLC lifted its position in shares of AMETEK by 2.1% in the 4th quarter. AlphaMark Advisors LLC now owns 3,348 shares of the technology company’s stock worth $604,000 after purchasing an additional 70 shares during the period. Finally, Geneos Wealth Management Inc. boosted its stake in shares of AMETEK by 42.9% during the 4th quarter. Geneos Wealth Management Inc. now owns 233 shares of the technology company’s stock valued at $42,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 87.43% of the company’s stock.

AMETEK Price Performance

Shares of NYSE AME opened at $187.91 on Friday. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.84 and a current ratio of 1.39. AMETEK has a fifty-two week low of $149.03 and a fifty-two week high of $198.33. The stock has a market cap of $43.47 billion, a PE ratio of 32.74, a price-to-earnings-growth ratio of 2.73 and a beta of 1.16. The stock has a fifty day moving average of $186.47 and a 200-day moving average of $175.84.

AMETEK (NYSE:AMEGet Free Report) last announced its quarterly earnings results on Thursday, October 31st. The technology company reported $1.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.04. The firm had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.71 billion. AMETEK had a net margin of 19.27% and a return on equity of 16.88%. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the prior year, the firm posted $1.64 earnings per share. Equities research analysts anticipate that AMETEK will post 6.8 earnings per share for the current year.

AMETEK Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 20th. Stockholders of record on Friday, December 6th were paid a dividend of $0.28 per share. The ex-dividend date was Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.60%. AMETEK’s dividend payout ratio (DPR) is currently 19.51%.

About AMETEK

(Get Free Report

AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.

Further Reading

Analyst Recommendations for AMETEK (NYSE:AME)

Receive News & Ratings for AMETEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMETEK and related companies with MarketBeat.com's FREE daily email newsletter.